Skip to content
MIT Science Policy Review

MIT Science Policy Review

MIT Science Policy Review
  • Article Categories
    • AI
    • Climate Change
    • Healthcare
    • Science Enterprise
    • Space & Security
  • Volumes
    • Volume I, December 2020
    • Volume II, August 2021
    • Volume III, August 2022
    • Volume IV, August 2023
  • Our Organization
    • About
    • Leadership
    • Editorial Board
    • Advisory Board
    • Sponsors
  • Contact
    • Contact Us
    • Subscribe
    • Write For Us
MIT Science Policy Review
  • Artificial Intelligence
  • Climate Change & Energy
  • Healthcare
  • Science Enterprise
  • Space & Security
  • Uncatagorized

Category: Healthcare

Healthcare

Repairing the prosthetic science-policy rift: Challenges to improved access to and translation of prosthetic technologies

Francesca Riccio-Ackerman3 Laura Chicos , and Guillermo Herrera-Arcos

Despite significant advances in prosthetic technologies, there are large gaps in patient accessibility for those who can benefit most from them.

View More Repairing the prosthetic science-policy rift: Challenges to improved access to and translation of prosthetic technologies
Healthcare

Unlocking the potential of psychedelics as medicine: Past obstacles and future outlooks

Sharon Y. Kim3 Rayven-Nikkita Collins , and Jimmy Teng

Psychedelics are effective in treating psychiatric conditions, but past stigmas and legal challenges threaten medicinal advancements.

View More Unlocking the potential of psychedelics as medicine: Past obstacles and future outlooks
Climate Change & Energy Healthcare

An interview with Dr. Emma J. Rosi: On ecosystem effects of pharmaceutical contamination

Rashi Jeeda , and Prachetas Jai Patel

A conversation about the effects of freshwater contamination from pharmaceutical products.

View More An interview with Dr. Emma J. Rosi: On ecosystem effects of pharmaceutical contamination
Healthcare

HIV vaccines: Lessons from basic research, clinical trials, and public policy

Andrew C. Saiz , and Kelsey L. Farenhem

HIV/AIDS still lacks a cure, but decades of research combined with public-private partnerships could be integral in delivering vaccines.

View More HIV vaccines: Lessons from basic research, clinical trials, and public policy
Healthcare

The next frontier of combating drug addiction in America

Cole Korponay

Evidence-based policies and new technologies may help the U.S. in the future of combating drug addiction.

View More The next frontier of combating drug addiction in America

Posts navigation

Page 1 Page 2 … Page 4 Next page

Recent Articles

Uncatagorized

A vision for policy education in science

Bertrand Neyhouse

MIT SPR’s Editor-in-Chief for Volume IV discusses what role the Review will play in educating scientists.

Artificial Intelligence

Algorithmic Bias: Looking Beyond Data Bias to Ensure Algorithmic Accountability and Equity

Savannah Thais3 Hannah Shumway , and Austin Iglesias Saragih

Minimizing bias in public sector algorithms requires holistic regulation.

Science Enterprise

Technologists as policy advisors: A conversation with Dr. Arati Prabhakar

Natalie D. Gehred , and Luke Petersen

A conversation about the role scientists and engineers play in public policy.

Content

  • AI
  • Climate Change
  • Healthcare
  • Science Enterprise

Resources

  • Our Organization
  • Leadership
  • Editorial Board
  • Advisory Board
  • Subscribe
  • Pitch an Article
  • Contact Us

Disclaimer

The views and opinions expressed are solely those of the authors and do not reflect the official position of MIT or the MIT Science Policy Review.

  • Licenses & Copyright

Follow us

Visit Us On TwitterVisit Us On FacebookVisit Us On Linkedin
MIT Science Policy Review | Designed by: Theme Freesia | WordPress | © Copyright All right reserved